SCHEMBL2299504

SCHEMBL2299504

O=c1c2ccccc2oc2cc(O)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 1.00
KDM4E B2RXH2 4/20 0.67
ALDH1A1 P00352 4/20 0.67
MAPT P10636 3/20 0.67
HSD17B10 Q99714 3/20 0.67
CYP3A4 P08684 3/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
CASP1 P29466 2/20 0.67
CASP7 P55210 2/20 0.67
GLA P06280 1/20 0.67
HPGD P15428 1/20 0.67
PGAM1 P18669 1/20 0.67
NPSR1 Q6W5P4 1/20 0.64
RXFP1 Q9HBX9 1/20 0.64
MGAM O43451 1/20 0.63
GAA P10253 1/20 0.63
SI P14410 1/20 0.63
MGAM2 Q2M2H8 1/20 0.63
TTR P02766 1/20 0.63
ALOX15 P16050 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29715739 1.00 MAOA (1.00) MAOAKDM4EALDH1A1MAPTHSD17B10
Acetic Acid SCHEMBL7328686 0.92 MAOA (0.84) MAOAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL30468736 0.90 MAOA (0.81) MAOAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL1983479 0.90 MAOA (0.81) MAOAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL1675981 0.89 MAOA (1.00) MAOAKDM4EALDH1A1MAPTHSD17B10
Xanthone SCHEMBL29025600 0.89 MAOA (1.00) MAOAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL30599042 0.89 MAOA (1.00) MAOAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL31153220 0.88 MAOA (0.79) MAOAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL2757860 0.88 MAOA (0.79) MAOAKDM4EALDH1A1MAPTHSD17B10
SCHEMBL7337235 0.87 MAOA (0.77) MAOAKDM4EALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011253-A Sieber resin and preparation method and application thereof 江苏海普功能材料有限公司 2026-05-12 CN claimed
WO-2024181781-A1 SUBSTRATE FOR SYNTHESIS OF BIOLOGICAL POLYMERS HAVING ANTI-AGGREGATION FUNCTION AND BIOLOGICAL POLYMER SYNTHESIS METHOD USING SAME 에스피투티엑스주식회사 2024-09-06 WO claimed
CN-116803999-A Preparation method of 3-hydroxy-9H-xanthen-9-one 安徽昊帆生物有限公司 2023-09-26 CN claimed
CN-109641997-B Curable resin composition, fuel cell using the same, and sealing method 三键有限公司 2021-12-28 CN claimed
US-11165072-B2 Curable resin composition, fuel cell using same, and sealing method using same THREEBOND CO., LTD. (JP) 2021-11-02 US claimed
EP-3330304-B1 PHOTOCURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD THREE BOND CO LTD (JP) 2020-07-15 EP claimed
EP-2908843-B1 TREATING CANCER AGENCY SCIENCE TECH & RES (SG) 2019-09-04 EP claimed
US-10092786-B2 Fire extinguishing composition comprising aldoketones compound XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) 2018-10-09 US claimed
US-20180195957-A1 COLOR SENSOR PROTECTIVE LAYER POLESTAR TECHNOLOGIES, INC (US) 2018-07-12 US claimed
US-20180120276-A1 GAS MOLECULE SENSOR POLESTAR TECHNOLOGIES, INC. 2018-05-03 US claimed
US-9889180-B2 Method of treating cancer AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-13 US claimed
US-20160332016-A1 Fire Extinguishing Composition Comprising Aldoketones Compound NANO FIRE, LLC 2016-11-17 US claimed
US-20150258175-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-09-17 US claimed
EP-2908843-A1 METHOD OF TREATING CANCER Agency For Science, Technology And Research (SG) 2015-08-26 EP claimed
WO-2014077784-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-05-22 WO claimed
EP-0620918-B1 CARBON DIOXIDE DETECTOR JOHNSON & JOHNSON PROFESSIONAL (GB) 1997-07-30 EP claimed
US-5480611-A Carbon dioxide detector GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC. 1996-01-02 US claimed
EP-0620918-A1 CARBON DIOXIDE DETECTOR. JOHNSON & JOHNSON PROFESSIONAL (GB) 1994-10-26 EP claimed
WO-1993014399-A1 CARBON DIOXIDE DETECTOR JOHNSON & JOHNSON PROFESSIONAL PRODUCTS LTD. (GB) 1993-07-22 WO claimed
CN-122011253-A Sieber resin and preparation method and application thereof 江苏海普功能材料有限公司 2026-05-12 CN disclosed
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES JOHNSON & JOHNSON SURGICAL VISION INC (US) 2026-04-23 US disclosed
US-20260062386-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE (US) 2026-03-05 US disclosed
US-12540247-B2 Primer composition THREEBOND CO., LTD. (JP) 2026-02-03 US disclosed
US-12509428-B2 Polymerizable fused tricyclic compounds as absorbers of UV and visible light JOHNSON & JOHNSON VISION CARE, INC. (US) 2025-12-30 US disclosed
US-20250362432-A1 OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS JOHNSON & JOHNSON VISION CARE (US) 2025-11-27 US disclosed
EP-4626495-A1 OPHTHALMIC LENS MATERIALS AND DEVICES MADE THEREOF Johnson & Johnson Surgical Vision, Inc. (US) 2025-10-08 EP disclosed
EP-3863862-B1 HIGH PRESSURE SENSITIVE COLOR CHANGEABLE INDICATORS AND METHODS OF MAKING SUCH INDICATORS THERMOGRAPHIC MEASUREMENTS LTD (GB) 2025-08-27 EP disclosed
WO-2025125986-A1 OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS JOHNSON & JOHNSON VISION CARE, INC. (US) 2025-06-19 WO disclosed
US-20250189826-A1 OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS JOHNSON & JOHNSON VISION CARE, INC. 2025-06-12 US disclosed
US-12306154-B2 Meltable color changeable indicators with organic polymer cores and methods of making such meltable indicators and composites thereof THERMOGRAPHIC MEASUREMENTS LIMITED (GB) 2025-05-20 US disclosed
EP-4540638-A1 OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS Johnson & Johnson Vision Care, Inc. (US) 2025-04-23 EP disclosed
US-12227542-B2 Method for producing peptide compound, protective group-forming reagent, and condensed polycyclic compound FUJIFILM CORPORATION (JP) 2025-02-18 US disclosed
CN-119376184-A Composition comprising a surface treatment component or a cure promoting component 三键有限公司 2025-01-28 CN disclosed
CN-119365797-A Ophthalmic devices comprising light stable mimics of macular pigments and other visible light filters 强生视力健公司 2025-01-24 CN disclosed
CN-119350286-A A series of multi-benzene ring photoinitiators and photoinitiator application thereof 湖北兴福电子材料股份有限公司 2025-01-24 CN disclosed
CN-112449635-B Polymerizable fused tricyclic compounds as UV and visible light absorbers 强生视力健公司 2024-10-29 CN disclosed
WO-2024181781-A1 SUBSTRATE FOR SYNTHESIS OF BIOLOGICAL POLYMERS HAVING ANTI-AGGREGATION FUNCTION AND BIOLOGICAL POLYMER SYNTHESIS METHOD USING SAME 에스피투티엑스주식회사 2024-09-06 WO disclosed
US-20240209129-A1 OPHTHALMIC LENS MATERIALS AND DEVICES MADE THEREOF Johnson & Johnson Surgical Vision, Inc. 2024-06-27 US disclosed
US-20240209129-A1 OPHTHALMIC LENS MATERIALS AND DEVICES MADE THEREOF Johnson & Johnson Surgical Vision, Inc. 2024-06-27 US disclosed
WO-2024116106-A1 OPHTHALMIC LENS MATERIALS AND DEVICES MADE THEREOF Johnson & Johnson Surgical Vision, Inc. (US) 2024-06-06 WO disclosed
WO-2024116106-A1 OPHTHALMIC LENS MATERIALS AND DEVICES MADE THEREOF Johnson & Johnson Surgical Vision, Inc. (US) 2024-06-06 WO disclosed
EP-3721193-B1 METHOD OF PRODUCING A COLOR CHANGEABLE POLYMERIC COMPOSITE THERMOGRAPHIC MEASUREMENTS LTD (GB) 2024-03-27 EP disclosed
WO-2023242688-A1 OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS JOHNSON & JOHNSON VISION CARE, INC. (US) 2023-12-21 WO disclosed
WO-2023242688-A1 OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS JOHNSON & JOHNSON VISION CARE, INC. (US) 2023-12-21 WO disclosed
US-20230357311-A1 METHOD FOR PRODUCING PEPTIDE, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND FUJIFILM CORPORATION (JP) 2023-11-09 US disclosed
US-20230357311-A1 METHOD FOR PRODUCING PEPTIDE, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND FUJIFILM CORPORATION (JP) 2023-11-09 US disclosed
US-20230357311-A1 METHOD FOR PRODUCING PEPTIDE, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND FUJIFILM CORPORATION (JP) 2023-11-09 US disclosed
EP-4269423-A1 METHOD FOR PRODUCING PEPTIDE, REAGENT FOR FORMING PROTECTIVE GROUP, AND FUSED POLYCYCLIC COMPOUND FUJIFILM Corporation (JP) 2023-11-01 EP disclosed
CN-116803999-A Preparation method of 3-hydroxy-9H-xanthen-9-one 安徽昊帆生物有限公司 2023-09-26 CN disclosed
CN-116803999-A Preparation method of 3-hydroxy-9H-xanthen-9-one 安徽昊帆生物有限公司 2023-09-26 CN disclosed
CN-116803999-A Preparation method of 3-hydroxy-9H-xanthen-9-one 安徽昊帆生物有限公司 2023-09-26 CN disclosed
US-20230117655-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2023-04-20 US disclosed
US-20230117655-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2023-04-20 US disclosed
US-20220411642-A1 PRIMER COMPOSITION THREEBOND CO., LTD. (JP) 2022-12-29 US disclosed
EP-4067442-A1 PRIMER COMPOSITION ThreeBond Co., Ltd. (JP) 2022-10-05 EP disclosed
WO-2022138605-A1 METHOD FOR PRODUCING PEPTIDE, REAGENT FOR FORMING PROTECTIVE GROUP, AND FUSED POLYCYCLIC COMPOUND 富士フイルム株式会社 2022-06-30 WO disclosed
US-11346786-B2 High pressure sensitive color changeable indicators and methods of making such indicators SENSOR INTERNATIONAL, LLC (US) 2022-05-31 US disclosed
EP-3992187-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND FUSED POLYCYCLIC COMPOUND FUJIFILM Corporation (JP) 2022-05-04 EP disclosed
EP-3990431-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT Johnson & Johnson Vision Care, Inc. (US) 2022-05-04 EP disclosed
CN-114401978-A Method for producing peptide compound 日产化学株式会社 2022-04-26 CN disclosed
US-20220112234-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND FUJIFILM CORPORATION (JP) 2022-04-14 US disclosed
CN-109641997-B Curable resin composition, fuel cell using the same, and sealing method 三键有限公司 2021-12-28 CN disclosed
US-11165072-B2 Curable resin composition, fuel cell using same, and sealing method using same THREEBOND CO., LTD. (JP) 2021-11-02 US disclosed
EP-3863862-A1 HIGH PRESSURE SENSITIVE COLOR CHANGEABLE INDICATORS AND METHODS OF MAKING SUCH INDICATORS Sensor International, LLC (US) 2021-08-18 EP disclosed
CN-112449635-A Polymerizable fused tricyclic compounds as absorbers of UV and visible light 强生视力健公司 2021-03-05 CN disclosed
WO-2021003295-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2021-01-07 WO disclosed
US-20200407324-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2020-12-31 US disclosed
US-20200407324-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2020-12-31 US disclosed
WO-2020261021-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. (US) 2020-12-30 WO disclosed
WO-2020261021-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. (US) 2020-12-30 WO disclosed
US-10840517-B2 Photocurable resin composition, fuel cell, and sealing method THREEBOND CO., LTD. (JP) 2020-11-17 US disclosed
EP-3721193-A1 MELTABLE COLOR CHANGEABLE INDICATORS WITH ORGANIC POLYMER CORES AND METHODS OF MAKING SUCH MELTABLE INDICATORS AND COMPOSITES THEREOF Sensor International, LLC (US) 2020-10-14 EP disclosed
US-10759976-B2 Color changeable adhesives and methods of making such adhesives SENSOR INTERNATIONAL, LLC (US) 2020-09-01 US disclosed
CN-107922554-B Photocurable resin composition, fuel cell, and sealing method 三键有限公司 2020-08-11 CN disclosed
EP-3330304-B1 PHOTOCURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD THREE BOND CO LTD (JP) 2020-07-15 EP disclosed
US-20200110036-A1 HIGH PRESSURE SENSITIVE COLOR CHANGEABLE INDICATORS AND METHODS OF MAKING SUCH INDICATORS BARINGS FINANCE LLC 2020-04-09 US disclosed
CN-110590901-A Method for quickly constructing trace peptide library and synthesis device thereof 浙江昂拓莱司生物技术有限公司 2019-12-20 CN disclosed
US-20190292421-A1 COLOR CHANGEABLE ADHESIVES AND METHODS OF MAKING SUCH ADHESIVES BARINGS FINANCE LLC 2019-09-26 US disclosed
EP-2908843-B1 TREATING CANCER AGENCY SCIENCE TECH & RES (SG) 2019-09-04 EP disclosed
US-20190263842-A1 NEW XANTHENE PROTECTIVE AGENT SEKISUI MEDICAL CO., LTD. (JP) 2019-08-29 US disclosed
EP-3511352-A1 CURABLE RESIN COMPOSITION, FUEL CELL USING SAME AND SEALING METHOD USING SAME Threebond Co., Ltd. (JP) 2019-07-17 EP disclosed
US-20190214659-A1 CURABLE RESIN COMPOSITION, FUEL CELL USING SAME, AND SEALING METHOD USING SAME THREEBOND CO., LTD. (JP) 2019-07-11 US disclosed
WO-2019113148-A1 MELTABLE COLOR CHANGEABLE INDICATORS WITH ORGANIC POLYMER CORES AND METHODS OF MAKING SUCH MELTABLE INDICATORS AND COMPOSITES THEREOF SENSOR INTERNATIONAL, LLC (US) 2019-06-13 WO disclosed
US-20190170714-A1 MELTABLE COLOR CHANGEABLE INDICATORS WITH ORGANIC POLYMER CORES AND METHODS OF MAKING SUCH MELTABLE INDICATORS AND COMPOSITES THEREOF BARINGS FINANCE LLC 2019-06-06 US disclosed
CN-109641997-A Curable resin composition, fuel cell using the same, and sealing method 三键有限公司 2019-04-16 CN disclosed
US-10092786-B2 Fire extinguishing composition comprising aldoketones compound XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) 2018-10-09 US disclosed
US-20180219235-A1 PHOTOCURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD THREEBOND CO., LTD. (JP) 2018-08-02 US disclosed
US-20180195957-A1 COLOR SENSOR PROTECTIVE LAYER POLESTAR TECHNOLOGIES, INC (US) 2018-07-12 US disclosed
EP-3330304-A1 PHOTOCURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD Threebond Co., Ltd. (JP) 2018-06-06 EP disclosed
US-20180120276-A1 GAS MOLECULE SENSOR POLESTAR TECHNOLOGIES, INC. 2018-05-03 US disclosed
US-9889180-B2 Method of treating cancer AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-13 US disclosed
WO-2018021233-A1 NEW XANTHENE PROTECTIVE AGENT 積水メディカル株式会社 2018-02-01 WO disclosed
US-20170329220-A1 PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, CURED PRODUCT, SEMICONDUCTOR DEVICE, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR PRODUCING CIRCUIT SUBSTRATE HITACHI CHEMICAL COMPANY, LTD. (JP) 2017-11-16 US disclosed
EP-2635561-B1 XANTHONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KK (JP) 2016-12-14 EP disclosed
EP-3095487-A1 FIRE EXTINGUISHING COMPOSITION COMPRISING ALDOKETONES COMPOUND Xi'an J&R Fire Fighting Equipment Co., Ltd. (CN) 2016-11-23 EP disclosed
US-20160332016-A1 Fire Extinguishing Composition Comprising Aldoketones Compound NANO FIRE, LLC 2016-11-17 US disclosed
US-9318712-B2 Xanthone compound and organic light-emitting device including the same CANON KABUSHIKI KAISHA (JP) 2016-04-19 US disclosed
US-9318712-B2 Xanthone compound and organic light-emitting device including the same CANON KABUSHIKI KAISHA (JP) 2016-04-19 US disclosed
US-9269911-B2 Organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2016-02-23 US disclosed
US-9269911-B2 Organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2016-02-23 US disclosed
US-20150258175-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-09-17 US disclosed
US-9128376-B2 Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method for manufacturing electronic device, and electronic device FUJIFILM CORPORATION (JP) 2015-09-08 US disclosed
EP-2908843-A1 METHOD OF TREATING CANCER Agency For Science, Technology And Research (SG) 2015-08-26 EP disclosed
CN-104231023-A Tricyclic fused-heterocyclic nucleoside phosphoramidate compound and preparation method and applications of tricyclic fused-heterocyclic nucleoside phosphoramidate compound NANJING SANHOME PHARMACEUTICAL CO LTD 2014-12-24 CN disclosed
US-20140248556-A1 PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2014-09-04 US disclosed
WO-2014077784-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-05-22 WO disclosed
US-8524682-B2 Compositions and methods for inhibiting EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2013-09-03 US disclosed
US-20130214268-A1 XANTHONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-22 US disclosed
US-20130214268-A1 XANTHONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-08-22 US disclosed
US-20130037791-A1 ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2013-02-14 US disclosed
US-20130037791-A1 ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2013-02-14 US disclosed
CN-102212067-B Garcinia derivative, method for preparing same and pharmaceutical application thereof UNIV CHINA PHARMA 2013-01-30 CN disclosed
WO-2012060234-A1 XANTHONE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-05-10 WO disclosed
CN-101528718-B Modulators of glucocorticoid receptor and/or AP-1 and/or NF- κ B activity and uses thereof BRISTOL MYERS SQUIBB CO 2011-11-09 CN disclosed
WO-2011136156-A1 ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2011-11-03 WO disclosed
US-20110251216-A1 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-10-13 US disclosed
CN-102212067-A Garcinia derivative, method for preparing same and pharmaceutical application thereof UNIV CHINA PHARMA 2011-10-12 CN disclosed
US-8034940-B2 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2011-10-11 US disclosed
US-8034940-B2 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2011-10-11 US disclosed
US-8034940-B2 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2011-10-11 US disclosed
WO-2011103016-A2 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-08-25 WO disclosed
US-20100222420-A1 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-09-02 US disclosed
CN-101528718-A Modulators of glucocorticoid receptor and/or AP-1 and/or NF- κ B activity and uses thereof BRISTOL MYERS SQUIBB CO (US) 2009-09-09 CN disclosed
EP-2049507-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF Brystol-Myers Squibb Company (US) 2009-04-22 EP disclosed
US-20090075995-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY 2009-03-19 US disclosed
US-20090075995-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY 2009-03-19 US disclosed
US-20090075995-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY 2009-03-19 US disclosed
US-20090012031-A1 EZH2 Cancer Markers THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2009-01-08 US disclosed
WO-2009006577-A2 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2009-01-08 WO disclosed
WO-2008021926-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO disclosed
WO-2008021926-A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AND/OR AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 WO disclosed
US-7235510-B2 Catalysts JOHNSON MATTHEY PLC (GB) 2007-06-26 US disclosed
US-20050164296-A1 reaction product of a meso-porous organofunctional silica and a ligand; organofunctional silica is prepared from an alkyl silicate and at least one organofunctional silane which contains a group reactive with ligand functional group JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2005-07-28 US disclosed
EP-1360004-B1 CATALYSTS JOHNSON MATTHEY PLC (GB) 2005-05-25 EP disclosed
US-6815481-B2 FUSED DIBENZO THERMAL STABILIZERS SUCH AS ANTHRACENE, XANTHENE AND ANTHRONE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-09 US disclosed
US-20030228619-A1 Peptide nucleic acids as tags in encoded libraries XENOPORT, INC. 2003-12-11 US disclosed
EP-1360004-A1 CATALYSTS Johnson Matthey PLC (GB) 2003-11-12 EP disclosed
US-6613797-B2 New xanthone derivatives useful for treating protozoan diseases INTERLAB, INC. 2003-09-02 US disclosed
US-6608089-B2 Having antiproliferative activity and are useful as modulators of multiple drug resistance in cancer chemotherapy of neoplasms, for use in manufacture of medicament for menopausal disorders and osteoporosis INDENA S.P.A. (IT) 2003-08-19 US disclosed
EP-1212312-B1 NOVEL DERIVATIVES OF FLAVONES, XANTHONES AND COUMARINS INDENA SPA (IT) 2003-04-02 EP disclosed
US-20020183318-A1 Having antiproliferative activity and are useful as modulators of multiple drug resistance in cancer chemotherapy of neoplasms, for use in manufacture of medicament for menopausal disorders and osteoporosis INDENA S.P.A. (IT) 2002-12-05 US disclosed
CN-1371371-A Novel derivatives of flavones, xanthones and coumarins INDENA SPA (IT) 2002-09-25 CN disclosed
WO-2002066159-A1 CATALYSTS JOHNSON MATTHEY PLC (GB) 2002-08-29 WO disclosed
EP-1212312-A1 NOVEL DERIVATIVES OF FLAVONES, XANTHONES AND COUMARINS INDENA S.p.A. (IT) 2002-06-12 EP disclosed
US-20020032256-A1 Polybutadiene composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-14 US disclosed
WO-2001017985-A1 NOVEL DERIVATIVES OF FLAVONES, XANTHONES AND COUMARINS INDENA S.P.A. (IT) 2001-03-15 WO disclosed
US-6133459-A HAVING ENZYME REACTIVE GROUP WHICH IS REMOVED BY THE ENZYME TO PROVIDE AN INTERMEDIATE DIOXETANE OXIDE ION WHICH DECOMPOSES SO THAT LIGHT IS GENERATED TROPIX, INC. (US) 2000-10-17 US disclosed
US-6107024-A USING 1,2-DIOXETANE DERIVATIVE SUBSTRATE IN ENZYME-LINKED ASSAY WHERE ENZYME IS LINKED TO ANTIGEN, ANTIBODY, HAPTEN OR NUCLEIC ACID; FORMS ARYLOXIDE INTERMEDIATE WHEN TRIGGERED, THEN RELEASES ENERGY TO FORM LIGHT AND TWO CARBONYL COMPOUNDS TROPIX, INC. (US) 2000-08-22 US disclosed
US-5981774-A PREPARING 3,5-DI(2,3-EPOXYPROPOXY)-1-HYDROXYXANTHONE BY REACTING 1,3,5-TRIMETHOXYXANTHONE WITH HYDROGEN IODIDE IN PHENOL WHEREBY 1,3,5-TRIHYDROXYXANTHONE IS OBTAINED, REACTING PRODUCT WITH EPICHLOROHYDRIN IN POTASSIUM HYDROXIDE NATIONAL SCIENCE COUNCIL (TW) 1999-11-09 US disclosed
US-5891626-A ENZYME-LINKED ANALYSIS; USING SURFACTANT TROPIX, INC. (US) 1999-04-06 US disclosed
US-5869698-A 1,2-dioxetane compounds as chemiluminescent labels for organic and biological molecules BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1999-02-09 US disclosed
US-5795987-A LUMINESCENCE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1998-08-18 US disclosed
EP-0352713-B2 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes TROPIX INC (US) 1998-07-08 EP disclosed
US-5741813-A ADMINISTERING SUBSTITUTED XANTHONES NATIONAL SCIENCE COUNCIL (TW) 1998-04-21 US disclosed
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 EP disclosed
US-5707559-A PROVIDING A STABLE 1,2-DIOXETANE WHICH FORMS INTERMEDIATE UNSTABLE COMPOUNDS WHEN TRIGGERED TO REMOVE BLOCKING GROUPS BY ACTIVATING AGENT SO THAT UNSTABLE COMPOUND DECOMPOSES TO FORM LIGHT AND TWO CARBONYL COMPOUNDS TROPIX, INC. (US) 1998-01-13 US disclosed
US-5698728-A CONTAIN ADAMANTYL MOIETY BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1997-12-16 US disclosed
EP-0620918-B1 CARBON DIOXIDE DETECTOR JOHNSON & JOHNSON PROFESSIONAL (GB) 1997-07-30 EP disclosed
US-5652345-A THERMALLY STABLE DIOXETANE TRIGGERED BY GALACTOSIDASE TO GENERATE CHEMILUMINESCENCE IN AQUEOUS SOLUTION TROPIX, INC. (US) 1997-07-29 US disclosed
CN-1035001-C Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1997-05-28 CN disclosed
US-5631353-A FLUID CAPSULES IN CONDUITS WITH SEGMENTS CONTAINING DIOXETANE REAGENTS AS ACTIVATORS BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1997-05-20 US disclosed
US-5616729-A FLUORESCENCE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1997-04-01 US disclosed
EP-0595369-B1 Alkene compounds TROPIX INC (US) 1996-12-04 EP disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
EP-0379716-B1 Chemiluminescent 1,2-dioxetane compounds TROPIX INC (US) 1996-03-13 EP disclosed
US-5495005-A ANTICOAGULANTS, CARDIOVASCULAR DISORDERS NATIONAL SCIENCE COUNCIL (TW) 1996-02-27 US disclosed
US-5480611-A Carbon dioxide detector GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC. 1996-01-02 US disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
US-5438146-A Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1995-08-01 US disclosed
US-5386017-A Can be converted to stable aryl substituted 1,2-dioxetanes which decompose when activated to produce light and carbonyl compounds BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1995-01-31 US disclosed
EP-0254051-B1 Chemiluminescent 1,2-dioxetane compounds UNIV WAYNE STATE (US) 1994-08-31 EP disclosed
CN-1088906-A The phenyl phenol leukotriene antagonists that replaces LILLY CO ELI (US) 1994-07-06 CN disclosed
EP-0595369-A1 Alkene compounds TROPIX, INC. (US) 1994-05-04 EP disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed
EP-0518387-A2 Method and composition providing enhanced chemiluminescence from 1,2-dioxetanes TROPIX, INC. (US) 1992-12-16 EP disclosed
EP-0510721-A2 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes TROPIX, INC. (US) 1992-10-28 EP disclosed
EP-0473984-A1 1,2-Dioxetane compounds as chemiluminescent labels for organic and biological molecules THE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1992-03-11 EP disclosed
US-5068339-A Labels for biomolecules BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1991-11-26 US disclosed
US-5013827-A Useful In Immunoassays BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1991-05-07 US disclosed
US-5004565-A Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes THE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1991-04-02 US disclosed
US-4962192-A Chemiluminescent 1,2-dioxetane compounds BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1990-10-09 US disclosed
US-4959182-A Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1990-09-25 US disclosed
EP-0379716-A1 Chemiluminescent 1,2-dioxetane compounds TROPIX, INC. (US) 1990-08-01 EP disclosed
WO-1990007511-A1 ENHANCED CHEMILUMINESCENCE FROM 1,2-DIOXETANES THROUGH ENERGY TRANSFER TO TETHERED FLUORESCERS BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1990-07-12 WO disclosed
EP-0352713-A1 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes TROPIX, INC. (US) 1990-01-31 EP disclosed
US-4857652-A Chemiluminescent 1,2-dioxetane compounds BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1989-08-15 US disclosed
EP-0254051-A2 Chemiluminescent 1,2-dioxetane compounds THE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1988-01-27 EP disclosed
EP-0105870-B1 MEASUREMENT DEVICE FOR DETERMINING THE CARBON DIOXIDE CONTENT OF A SAMPLE AVL AG (CH) 1987-02-11 EP disclosed
EP-0105870-A2 Measurement device for determining the carbon dioxide content of a sample AVL AG (CH) 1984-04-18 EP disclosed
US-4404220-A INSECTIDES VELSICOL CHEMICAL CORPORATION (US) 1983-09-13 US disclosed
US-4299772-A INSECTICIDES VELSICOL CHEMICAL CORPORATION (US) 1981-11-10 US disclosed
US-4005208-A GASTRIC JUICE, ANTISECRETORY SMITHKLINE CORPORATION (US) 1977-01-25 US disclosed
US-3980788-A XANTHENYL COMPOUNDS SMITHKLINE CORPORATION (US) 1976-09-14 US disclosed
US-3961069-A ANTISECRETORY AGENTS, GASTRIC ACID SMITHKLINE CORPORATION (US) 1976-06-01 US disclosed
US-3949076-A GASTRIC ACID SECRETION INHIBITION SMITHKLINE CORPORATION (US) 1976-04-06 US disclosed
US-3949076-A GASTRIC ACID SECRETION INHIBITION SMITHKLINE CORPORATION (US) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227542-B2 Method for producing peptide compound, protective group-forming reagent, and condensed polycyclic compound C9, GRPR, VIP MAOA 3421/4885KDM4E 4117/4885ALDH1A1 3782/4885
US-12540247-B2 Primer composition FGB, CDH1, F10 MAOA 86/4885KDM4E 822/4885ALDH1A1 1171/4885
US-20260110920-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, ERCC5, ERCC4 MAOA 3809/4885KDM4E 2560/4885ALDH1A1 3021/4885
US-20230357311-A1 METHOD FOR PRODUCING PEPTIDE, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND C9, VIP, NGLY1 MAOA 3625/4885KDM4E 3985/4885ALDH1A1 3024/4885
US-20200407324-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT ERCC4, ERCC1, F12 MAOA 781/4885KDM4E 2856/4885ALDH1A1 957/4885
US-20260062386-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT ERCC1, MCM6, GPR6 MAOA 1616/4885KDM4E 3698/4885ALDH1A1 3065/4885
US-20260109796-A1 MATERIALS AND METHODS FOR LIGHT ADJUSTABLE OPHTHALMIC DEVICES ERCC1, PDE6H, HCK MAOA 4598/4885KDM4E 1516/4885ALDH1A1 2416/4885
US-20110251216-A1 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 EZH2, BMI1, EZH1 MAOA 4389/4885KDM4E 85/4885ALDH1A1 3791/4885
US-20090075995-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF NFKB2, NFRKB, NFKB1 MAOA 4525/4885KDM4E 1666/4885ALDH1A1 3409/4885
US-20020183318-A1 Having antiproliferative activity and are useful as modulators of multiple drug resistance in cancer chemotherapy of neoplasms, for use in manufacture of medicament for menopausal disorders and osteoporosis BRCA1, NCEH1, EZH1 MAOA 3604/4885KDM4E 2953/4885ALDH1A1 2996/4885
US-20190263842-A1 NEW XANTHENE PROTECTIVE AGENT XDH, XPA, XPO7 MAOA 1056/4885KDM4E 4101/4885ALDH1A1 2958/4885
US-20220112234-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND C9, GRPR, VIP MAOA 3421/4885KDM4E 4117/4885ALDH1A1 3782/4885
US-12509428-B2 Polymerizable fused tricyclic compounds as absorbers of UV and visible light ERCC1, OGG1, ERCC4 MAOA 1377/4885KDM4E 701/4885ALDH1A1 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.